AKZO'S DIOSYNTH PLANT PROVES A HARD SELL

Organon, Akzo Nobel's healthcare division, has conceded it will have to close its Diosynth manufacturing plant in Scotland by the end of the year since it cannot divest it, as the unit's lack of competitiveness in the production of fine chemicals and pharmaceutical starting materials appears insurmountable.

In-PharmaTechnologist.com (http://www.in-pharmatechnologist.com/news/ng.asp?n=66643-akzo-nobel-organon-diosynth-active-pharmaceutical-ing)